4.6 Review

Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition

Bing Z. Carter et al.

Summary: MCL-1 and BCL-2 are both overexpressed in acute myeloid leukemia (AML) and play crucial roles in the survival of AML cells and stem cells. Inhibition of MCL-1 enhances the sensitivity to BCL-2 inhibition and improves the efficacy of treatment. Additionally, MCL-1 regulates cell metabolism and leukemia-stromal interactions, providing new mechanisms for AML development.

HAEMATOLOGICA (2022)

Review Oncology

Catch me if you can: how AML and its niche escape immunotherapy

Sarah Tettamanti et al.

Summary: Despite progress in AML research, the survival rate for patients remains low, highlighting the need for innovative therapies. Recent focus has been on immunotherapeutic strategies targeting leukemic cells, but studies emphasize the role of the leukemic microenvironment in facilitating tumor escape mechanisms. A rational combination of complementary immunotherapy strategies may be beneficial in preventing escape mechanisms without increasing toxicity in the complex AML landscape.

LEUKEMIA (2022)

Article Hematology

An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia

Simone Ragaini et al.

Summary: The study highlights the key role of IDO1 in constructing an immune gene signature predictive of survival in AML patients, with PLXNC1 being the gene interacting with IDO1 that retains the strongest prognostic value. Incorporating PLXNC1 into the score based on IDO1 and BIN1 can enhance the accuracy of survival prediction.

BLOOD ADVANCES (2022)

Review Oncology

Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways

Saeid Taghiloo et al.

Summary: Immune surveillance mechanisms are designed to eliminate AML development, but leukemic cells use immune evasion mechanisms to resist host immune responses, leading to tumor progression. While immune checkpoint inhibitors have achieved success in tumor-targeted therapy, their effectiveness in AML patients is less remarkable.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Review Oncology

Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy

Stefania Trino et al.

Summary: Liquid biopsy is becoming increasingly important in oncology within the era of precision medicine, allowing for the isolation and analysis of tumor-derived biomarkers such as extracellular vesicles (EVs) in body fluids. EVs, as lipid bilayer-enclosed particles, have emerged as valuable carriers of cancer information, offering potential as novel biomarkers due to their molecular cargo mirroring parental cell characteristics. The translation of these new diagnostic tools into clinical practice has the potential to deeply revolutionize the field of cancer research.

LEUKEMIA (2021)

Article Cell Biology

Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion

Dexiang Ji et al.

Summary: This study demonstrates that small-sized EVs secreted by BMSCs of AML patients regulate AML progression by transferring miR-26a-5p, promoting cell proliferation, migration, and invasion. Additionally, these EVs inhibit GSK3 beta expression and activate the Wnt/beta-catenin pathway in AML cells, ultimately contributing to AML progression.

HUMAN CELL (2021)

Review Oncology

T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

Naval Daver et al.

Summary: AML is a heterogeneous disease with a broad spectrum of molecular abnormalities, requiring multiple therapeutic approaches for long-term disease control. Recent advancements in understanding and targeting these molecular aberrations have led to rapid evolution in AML treatment, with a focus on immunotherapies harnessing T cells. Multiple T-cell-based immunotherapies, including bispecific antibodies, CAR T-cell therapies, and immune checkpoint inhibitors, are in various stages of development for AML treatment.

LEUKEMIA (2021)

Article Oncology

CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration

Kirsti L. Walker et al.

Summary: Combination therapy with ruxolitinib and venetoclax shows promise for treating T-ALL, but additional inhibition of the CXCR4-CXCL12 axis may be needed to maximize the possibility of complete remission.

LEUKEMIA & LYMPHOMA (2021)

Article Multidisciplinary Sciences

Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression

Marie-Theresa Weickert et al.

Summary: The study found that BMSC from MDS and AML patients had a reduced CFU-F frequency, altered phenotype and lower replating efficiency. Gene expression analysis showed significantly decreased levels of the early adipogenic cell fate inhibitor DLK1 in MDS and AML BMSC, along with significantly increased in vitro adipogenic differentiation potential.

SCIENTIFIC REPORTS (2021)

Review Oncology

Immunotherapy in Acute Myeloid Leukemia: Where We Stand

Alessandro Isidori et al.

Summary: Recent advances in understanding the pathogenesis of acute myeloid leukemia (AML) have accelerated the discovery of new drugs and innovative therapeutic approaches, with a particular focus on the role of the immune system in AML development. Efforts in immune therapy have shown promise in improving survival rates for AML patients by targeting leukemia stem cells and utilizing various modalities such as T cell therapy, checkpoint blockade, and leukemia vaccines.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Mitochondrial metabolism as a target for acute myeloid leukemia treatment

Svetlana B. Panina et al.

Summary: Unique mitochondrial alterations in AML cells have become a focus of research, potentially providing new treatment targets. Mitochondria are related to multiple metabolic pathways, and some mitochondria-targeting chemotherapeutics have been FDA-approved. New studies focus on revealing the effects of drugs targeting mitochondria and their potential.

CANCER & METABOLISM (2021)

Article Oncology

Exosomes from BM-MSCs promote acute myeloid leukemia cell proliferation, invasion and chemoresistance via upregulation of S100A4

Tianxin Lyu et al.

Summary: This study revealed that BM-MSC-exos increased the metastatic potential, maintained stemness, and contributed to chemoresistance of leukemia cells by upregulating S100A4. Downregulation of S100A4 suppressed proliferation, invasion, and chemoresistance of leukemia cells, indicating its potential as a therapeutic target in leukemia. Bioinformatic analysis from TCGA database showed S100A4's association with poor prognosis in AML patients and its involvement in cell-cell adhesion and cytokine regulation processes.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Review Oncology

New strategies to treat AML: novel insights into AML survival pathways and combination therapies

Ramya Nair et al.

Summary: The treatment of acute myeloid leukemia (AML) is challenging due to its heterogeneity, leading to a shift towards personalized treatment based on genomic signature. Novel insights into AML survival pathways, including drug resistance and immune system evasion, are being revealed. The combination of drugs or treatments has shown enhanced clinical efficiencies, prompting further investigation into targeted pathways for increased treatment response.

LEUKEMIA (2021)

Article Hematology

Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study

Daniel A. Pollyea et al.

Summary: This study provides the longest-term follow-up analysis for AML patients treated with venetoclax plus azacitidine or decitabine. The results indicate that venetoclax plus hypomethylating agents are highly effective frontline therapies for AML patients unfit for intensive chemotherapy.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Review Oncology

Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment

Jill Nehrbas et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

Yoko Tabe et al.

FRONTIERS IN ONCOLOGY (2020)

Review Medicine, Research & Experimental

Immune escape and immunotherapy of acute myeloid leukemia

Luca Vago et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Cell Biology

Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance

Nick van Gastel et al.

CELL METABOLISM (2020)

Review Oncology

Targeting immune checkpoints in hematological malignancies

Basit Salik et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Cell Biology

Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

Jayakumar Vadakekolathu et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Oncology

Diagnostic and Therapeutic Potential of Extracellular Vesicles in B-Cell Malignancies

Ernesto Gargiulo et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Targeting CXCR4 in AML and ALL

Daniel Cancilla et al.

FRONTIERS IN ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Involvement of GPx-3 in the Reciprocal Control of Redox Metabolism in the Leukemic Niche

Christine Vignon et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis

Masayuki Yamashita et al.

NATURE REVIEWS CANCER (2020)

Article Biochemistry & Molecular Biology

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori et al.

NATURE MEDICINE (2019)

Review Biotechnology & Applied Microbiology

Mechanisms of drug resistance in acute myeloid leukemia

Jing Zhang et al.

ONCOTARGETS AND THERAPY (2019)

Article Oncology

Targeting Glutamine Metabolism and Redox State for Leukemia Therapy

Mark A. Gregory et al.

CLINICAL CANCER RESEARCH (2019)

Review Immunology

The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells

Emeka B. Okeke et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Cell Biology

Metabolic Plasticity of Acute Myeloid Leukemia

Johanna Kreitz et al.

Review Multidisciplinary Sciences

A view on drug resistance in cancer

Neil Vasan et al.

NATURE (2019)

Review Chemistry, Multidisciplinary

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Feng Xie et al.

ADVANCED SCIENCE (2019)

Review Immunology

T Regulatory Cells and Priming the Suppressive Tumor Microenvironment

Christina M. Paluskievicz et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

Article Biochemistry & Molecular Biology

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina et al.

NATURE MEDICINE (2018)

Article Medicine, General & Internal

Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

M. J. Christopher et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

Targeting regulatory T cells for improving cancer therapy: Challenges and prospects

Bilikere S. Dwarakanath et al.

CANCER REPORTS (2018)

Review Oncology

Oxidative stress response induced by chemotherapy in leukemia treatment

Jin Zhang et al.

MOLECULAR AND CLINICAL ONCOLOGY (2018)

Review Hematology

Tumor necrosis factor a in the onset and progression of leukemia

Xiaoxi Zhou et al.

EXPERIMENTAL HEMATOLOGY (2017)

Review Biochemistry & Molecular Biology

Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy

Antonella Caivano et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Immunology

Tregs: where we Are and what Comes Next?

Hai Zhao et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Oncology

Mitochondrial Transfer in the Leukemia Microenvironment

Emmanuel Griessinger et al.

TRENDS IN CANCER (2017)

Review Oncology

Discovery of IDO1 Inhibitors: From Bench to Bedside

George C. Prendergast et al.

CANCER RESEARCH (2017)

Article Cell & Tissue Engineering

Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche

Haobin Ye et al.

CELL STEM CELL (2016)

Review Oncology

Harnessing the immune system in acute myeloid leukaemia

Rebecca Austin et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)

Review Biochemistry & Molecular Biology

Targeting regulatory T cells in tumors

Chang Liu et al.

FEBS JOURNAL (2016)

Article Multidisciplinary Sciences

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

Nicholas McGranahan et al.

SCIENCE (2016)

Review Cell Biology

Acetyl Coenzyme A: A Central Metabolite and Second Messenger

Federico Pietrocola et al.

CELL METABOLISM (2015)

Review Cell Biology

Treg(s) in Cancer: Friends or Foe?

Dominik Wolf et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2015)

Review Multidisciplinary Sciences

T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis

Ying-Hua Wang et al.

Review Immunology

Regulatory T cells in cancer immunotherapy

Hiroyoshi Nishikawa et al.

CURRENT OPINION IN IMMUNOLOGY (2014)

Review Immunology

The two faces of IL-6 in the tumor microenvironment

Daniel T. Fisher et al.

SEMINARS IN IMMUNOLOGY (2014)

Article Hematology

Clinical significance of Treg cell frequency in acute myeloid leukemia

Wenjuan Yang et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)

Article Biochemistry & Molecular Biology

Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells

Shanshan Pei et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Multidisciplinary Sciences

Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells

Eri Taniguchi Ishikawa et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Cell & Tissue Engineering

Patterns of Amino Acid Metabolism by Proliferating Human Mesenchymal Stem Cells

Gustavo A. Higuera et al.

TISSUE ENGINEERING PART A (2012)

Review Hematology

Do reactive oxygen species play a role in myeloid leukemias?

Paul Spencer Hole et al.

Article Medicine, Research & Experimental

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2R gamma c-deficient mice

Jean-Emmanuel Sarry et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biochemistry & Molecular Biology

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

Kristin M. Nieman et al.

NATURE MEDICINE (2011)

Article Medicine, Research & Experimental

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

Ismael Samudio et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Oncology

Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation

Kazuto Suganuma et al.

LEUKEMIA & LYMPHOMA (2010)

Article Multidisciplinary Sciences

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Simon Mendez-Ferrer et al.

NATURE (2010)

Review Cell & Tissue Engineering

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Soufiane Ghannam et al.

STEM CELL RESEARCH & THERAPY (2010)

Article Oncology

Adipocytes Impair Leukemia Treatment in Mice

James W. Behan et al.

CANCER RESEARCH (2009)

Article Oncology

Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia

Miroslaw J. Szczepanski et al.

CLINICAL CANCER RESEARCH (2009)

Article Medicine, General & Internal

Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.

Luca Vago et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Review Immunology

Mesenchymal stem cells in health and disease

Antonio Uccelli et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Review Medicine, Research & Experimental

Immune surveillance of tumors

Jeremy B. Swann et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Medicine, Research & Experimental

Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase

Shotaro Iwamoto et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Multidisciplinary Sciences

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9

Andrei V. Krivtsov et al.

NATURE (2006)

Review Immunology

IDO expression by dendritic cells: Tolerance and tryptophan catabolism

AL Mellor et al.

NATURE REVIEWS IMMUNOLOGY (2004)